BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19650177)

  • 1. Complementary-alternative medicine among cancer patients in the western region of Turkey.
    Tarhan O; Alacacioglu A; Somali I; Sipahi H; Zencir M; Oztop I; Dirioz M; Yilmaz U
    J BUON; 2009; 14(2):265-9. PubMed ID: 19650177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary/alternative medicine use in a pediatric oncology unit in Turkey.
    Karadeniz C; Pinarli FG; Oğuz A; Gürsel T; Canter B
    Pediatr Blood Cancer; 2007 May; 48(5):540-3. PubMed ID: 16900485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of complementary and alternative (non-conventional) medicine in cancer patients in Turkey.
    Algier LA; Hanoglu Z; Ozden G; Kara F
    Eur J Oncol Nurs; 2005 Jun; 9(2):138-46. PubMed ID: 15899593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life and complementary and alternative medicine use among cancer patients in Turkey.
    Can G; Erol O; Aydiner A; Topuz E
    Eur J Oncol Nurs; 2009 Sep; 13(4):287-94. PubMed ID: 19395312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre.
    Chrystal K; Allan S; Forgeson G; Isaacs R
    N Z Med J; 2003 Jan; 116(1168):U296. PubMed ID: 12601420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence and determinants of the use of complementary and alternative medicine in adult Turkish cancer patients.
    Tas F; Ustuner Z; Can G; Eralp Y; Camlica H; Basaran M; Karagol H; Sakar B; Disci R; Topuz E
    Acta Oncol; 2005; 44(2):161-7. PubMed ID: 15788296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting the use of complementary and alternative therapies among cancer patients in Iran.
    Montazeri A; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I
    Eur J Cancer Care (Engl); 2007 Mar; 16(2):144-9. PubMed ID: 17371423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-application of complementary and alternative medicine by patients with gynecologic cancer.
    Akyuz A; Dede M; Cetinturk A; Yavan T; Yenen MC; Sarici SU; Dilek S
    Gynecol Obstet Invest; 2007; 64(2):75-81. PubMed ID: 17308388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there any difference in the use of complementary and alternative therapies in patients asthma and COPD? A cross-sectional survey.
    Argüder E; Bavbek S; Sen E; Köse K; Keskin O; Saryal S; Misirligil Z
    J Asthma; 2009 Apr; 46(3):252-8. PubMed ID: 19373632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of complementary and alternative medicine by patients with cancer: in Turkey.
    Akyol AD; Oz B
    Complement Ther Clin Pract; 2011 Nov; 17(4):230-4. PubMed ID: 21982139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of complementary and alternative medicine by cancer patients at the University of Nigeria Teaching Hospital, Enugu, Nigeria.
    Ezeome ER; Anarado AN
    BMC Complement Altern Med; 2007 Sep; 7():28. PubMed ID: 17850665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medications consumed by renal patients in southern Germany.
    Nowack R; Ballé C; Birnkammer F; Koch W; Sessler R; Birck R
    J Ren Nutr; 2009 May; 19(3):211-9. PubMed ID: 19251442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary medicine use in children and young adults with inflammatory bowel disease.
    Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
    Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
    Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
    J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary and alternative medicine use by primary care patients with chronic pain.
    Rosenberg EI; Genao I; Chen I; Mechaber AJ; Wood JA; Faselis CJ; Kurz J; Menon M; O'Rorke J; Panda M; Pasanen M; Staton L; Calleson D; Cykert S
    Pain Med; 2008 Nov; 9(8):1065-72. PubMed ID: 18564996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementary and alternative medicine use in lung cancer patients in eight European countries.
    Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
    Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary and alternative medicine among cancer patients in Israel.
    Pud D; Kaner E; Morag A; Ben-Ami S; Yaffe A
    Eur J Oncol Nurs; 2005 Jun; 9(2):124-30. PubMed ID: 15944105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics.
    Hasan SS; Ahmed SI; Bukhari NI; Loon WC
    Complement Ther Clin Pract; 2009 Aug; 15(3):152-7. PubMed ID: 19595416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary and alternative medicine used by pediatric patients with cancer in western Turkey.
    Genc RE; Senol S; Turgay AS; Kantar M
    Oncol Nurs Forum; 2009 May; 36(3):E159-64. PubMed ID: 19403444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
    Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
    Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.